Several serum biomarkers have been proposed for RA-ILD diagnosis, including antibodies (ie. RF and ACPA) (11, 12) and a range of cytokines and growth factors released by active specialized macrophages and stromal cells (ie. MMP-7, surface protein D, and KL-6) (16, 17). The gene discussed is PRTN3; the disease is interstitial lung disease.